Publication: Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies
dc.contributor.author | Petrovas, Constantinos | |
dc.contributor.author | Ferrando-Martinez, Sara | |
dc.contributor.author | Gerner, Michael Y. | |
dc.contributor.author | Casazza, Joseph P. | |
dc.contributor.author | Pegu, Amarendra | |
dc.contributor.author | Deleage, Claire | |
dc.contributor.author | Cooper, Arik | |
dc.contributor.author | Hataye, Jason | |
dc.contributor.author | Andrews, Sarah | |
dc.contributor.author | Ambrozak, David | |
dc.contributor.author | Del Rio Estrada, Perla M. | |
dc.contributor.author | Boritz, Eli | |
dc.contributor.author | Paris, Robert | |
dc.contributor.author | Moysi, Eirini | |
dc.contributor.author | Boswell, Kristin L. | |
dc.contributor.author | Ruiz-Mateos, Ezequiel | |
dc.contributor.author | Vagios, Ilias | |
dc.contributor.author | Leal, Manuel | |
dc.contributor.author | Ablanedo-Terrazas, Yuria | |
dc.contributor.author | Rivero, Amaranta | |
dc.contributor.author | Alicia Gonzalez-Hernandez, Luz | |
dc.contributor.author | McDermott, Adrian B. | |
dc.contributor.author | Moir, Susan | |
dc.contributor.author | Reyes-Teran, Gustavo | |
dc.contributor.author | Docobo, Fernando | |
dc.contributor.author | Pantaleo, Giuseppe | |
dc.contributor.author | Douek, Daniel C. | |
dc.contributor.author | Betts, Michael R. | |
dc.contributor.author | Estes, Jacob D. | |
dc.contributor.author | Germain, Ronald N. | |
dc.contributor.author | Mascola, John R. | |
dc.contributor.author | Koup, Richard A. | |
dc.contributor.authoraffiliation | [Petrovas, Constantinos] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA | |
dc.contributor.authoraffiliation | [Ferrando-Martinez, Sara] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA | |
dc.contributor.authoraffiliation | [Casazza, Joseph P.] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA | |
dc.contributor.authoraffiliation | [Hataye, Jason] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA | |
dc.contributor.authoraffiliation | [Ambrozak, David] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA | |
dc.contributor.authoraffiliation | [Moysi, Eirini] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA | |
dc.contributor.authoraffiliation | [Boswell, Kristin L.] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA | |
dc.contributor.authoraffiliation | [Koup, Richard A.] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA | |
dc.contributor.authoraffiliation | [Gerner, Michael Y.] NIAID, Lab Syst Biol, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA | |
dc.contributor.authoraffiliation | [Germain, Ronald N.] NIAID, Lab Syst Biol, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA | |
dc.contributor.authoraffiliation | [Pegu, Amarendra] NIAID, Virol Lab, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA | |
dc.contributor.authoraffiliation | [Cooper, Arik] NIAID, Virol Lab, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA | |
dc.contributor.authoraffiliation | [Mascola, John R.] NIAID, Virol Lab, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA | |
dc.contributor.authoraffiliation | [Deleage, Claire] Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Leidos Biomed Res Inc, BG 535,POB B, Frederick, MD 21702 USA | |
dc.contributor.authoraffiliation | [Estes, Jacob D.] Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Leidos Biomed Res Inc, BG 535,POB B, Frederick, MD 21702 USA | |
dc.contributor.authoraffiliation | [Andrews, Sarah] NIAID, Immunol Core Sect, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA | |
dc.contributor.authoraffiliation | [McDermott, Adrian B.] NIAID, Immunol Core Sect, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA | |
dc.contributor.authoraffiliation | [Del Rio Estrada, Perla M.] Inst Nacl Enfermedades Resp, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico | |
dc.contributor.authoraffiliation | [Ablanedo-Terrazas, Yuria] Inst Nacl Enfermedades Resp, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico | |
dc.contributor.authoraffiliation | [Rivero, Amaranta] Inst Nacl Enfermedades Resp, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico | |
dc.contributor.authoraffiliation | [Alicia Gonzalez-Hernandez, Luz] Inst Nacl Enfermedades Resp, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico | |
dc.contributor.authoraffiliation | [Reyes-Teran, Gustavo] Inst Nacl Enfermedades Resp, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico | |
dc.contributor.authoraffiliation | [Boritz, Eli] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA | |
dc.contributor.authoraffiliation | [Douek, Daniel C.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA | |
dc.contributor.authoraffiliation | [Paris, Robert] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA | |
dc.contributor.authoraffiliation | [Ruiz-Mateos, Ezequiel] Univ Seville, Lab Immunovirol, Hosp Univ Virgen Rocio, Inst Biomed Sevilla,CSIC, Seville 41013, Spain | |
dc.contributor.authoraffiliation | [Leal, Manuel] Univ Seville, Lab Immunovirol, Hosp Univ Virgen Rocio, Inst Biomed Sevilla,CSIC, Seville 41013, Spain | |
dc.contributor.authoraffiliation | [Docobo, Fernando] Univ Seville, Lab Immunovirol, Hosp Univ Virgen Rocio, Inst Biomed Sevilla,CSIC, Seville 41013, Spain | |
dc.contributor.authoraffiliation | [Vagios, Ilias] Venizeleio Hosp, Dept Histopathol, Iraklion, Crete, Greece | |
dc.contributor.authoraffiliation | [Moir, Susan] NIAID, Immunoregulat Lab, Bldg 10, Bethesda, MD 20892 USA | |
dc.contributor.authoraffiliation | [Pantaleo, Giuseppe] Univ Lausanne, Univ Lausanne Hosp, Dept Med, Serv Immunol & Allergy,Serv Infect Dis, CH-1011 Lausanne, Switzerland | |
dc.contributor.authoraffiliation | [Pantaleo, Giuseppe] Univ Lausanne, Univ Lausanne Hosp, Swiss Vaccine Res Inst, CH-1011 Lausanne, Switzerland | |
dc.contributor.authoraffiliation | [Betts, Michael R.] Univ Penn, Dept Microbiol, Ctr AIDS Res, Perelman Sch Med, Philadelphia, PA 19104 USA | |
dc.contributor.authoraffiliation | [Betts, Michael R.] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA | |
dc.contributor.authoraffiliation | [Gerner, Michael Y.] Univ Washington, Dept Immunol, Seattle, WA 98109 USA | |
dc.contributor.funder | VRC, NIAID, NIH | |
dc.contributor.funder | Bill and Melinda Gates Foundation | |
dc.contributor.funder | National Cancer Institute, NIH | |
dc.contributor.funder | Redes Telematicas de Investigacion Cooperativa en Salud (RETICS; Red de SIDA) | |
dc.contributor.funder | Fondo de Investigacion Sanitaria | |
dc.contributor.funder | NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES | |
dc.date.accessioned | 2023-02-12T02:21:35Z | |
dc.date.available | 2023-02-12T02:21:35Z | |
dc.date.issued | 2017-01-18 | |
dc.description.abstract | Cytolytic CD8 T cells play a crucial role in the control and elimination of virus-infected cells and are a major focus of HIV cure efforts. However, it has been shown that HIV-specific CD8 T cells are infrequently found within germinal centers (GCs), a predominant site of active and latent HIV infection. We demonstrate that HIV infection induces marked changes in the phenotype, frequency, and localization of CD8 T cells within the lymph node (LN). Significantly increased frequencies of CD8 T cells in the B cell follicles and GCs were found in LNs from treated and untreated HIV-infected individuals. This profile was associated with persistent local immune activation but did not appear to be directly related to local viral replication. Follicular CD8 (fCD8) T cells, despite compromised cytokine polyfunctionality, showed good cytolytic potential characterized by high ex vivo expression of granzyme B and perforin. We used an anti-HIV/anti-CD3 bispecific antibody in a redirected killing assay and found that fCD8 T cells had better killing activity than did non-fCD8 T cells. Our results indicate that CD8 T cells with potent cytolytic activity are recruited to GCs during HIV infection and, if appropriately redirected to kill HIV-infected cells, could be an effective component of an HIV cure strategy. | |
dc.identifier.doi | 10.1126/scitranslmed.aag2285 | |
dc.identifier.essn | 1946-6242 | |
dc.identifier.issn | 1946-6234 | |
dc.identifier.unpaywallURL | https://europepmc.org/articles/pmc5497679?pdf=render | |
dc.identifier.uri | http://hdl.handle.net/10668/18997 | |
dc.identifier.wosID | 394447000004 | |
dc.issue.number | 373 | |
dc.journal.title | Science translational medicine | |
dc.journal.titleabbreviation | Sci. transl. med. | |
dc.language.iso | en | |
dc.organization | Instituto de Biomedicina de Sevilla-IBIS | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.publisher | Amer assoc advancement science | |
dc.rights.accessRights | open access | |
dc.subject | Human-immunodeficiency-virus | |
dc.subject | Lymph-nodes | |
dc.subject | Replication | |
dc.subject | Effector | |
dc.subject | Lymphocytes | |
dc.subject | Activation | |
dc.subject | Responses | |
dc.subject | Tissue | |
dc.subject | Rna | |
dc.subject | Expansion | |
dc.title | Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies | |
dc.type | research article | |
dc.type.hasVersion | AM | |
dc.volume.number | 9 | |
dc.wostype | Article | |
dspace.entity.type | Publication |